Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) insider Edwin Reisz sold 17,613 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total transaction of $138,262.05. Following the sale, the insider owned 1,321,114 shares of the company’s stock, valued at $10,370,744.90. This represents a 1.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Aveanna Healthcare Stock Down 1.1%
Shares of NASDAQ AVAH traded down $0.09 during mid-day trading on Friday, reaching $8.08. The company had a trading volume of 2,526,966 shares, compared to its average volume of 1,076,101. The firm has a 50 day simple moving average of $8.92 and a two-hundred day simple moving average of $7.49. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.67 and a 52-week high of $10.32. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a market cap of $1.69 billion, a P/E ratio of 22.44 and a beta of 2.06.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. Sell-side analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.
Institutional Investors Weigh In On Aveanna Healthcare
Analysts Set New Price Targets
A number of research analysts recently issued reports on the company. Truist Financial raised their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a research note on Friday, November 7th. Raymond James Financial reissued an “outperform” rating and issued a $13.00 price objective on shares of Aveanna Healthcare in a report on Friday, December 5th. Jefferies Financial Group lifted their target price on shares of Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a report on Tuesday, October 28th. UBS Group upped their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research report on Friday, November 7th. Finally, JPMorgan Chase & Co. upgraded shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and increased their price target for the stock from $6.00 to $10.00 in a research note on Thursday, September 18th. Five equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.69.
Get Our Latest Stock Report on AVAH
Aveanna Healthcare Company Profile
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Read More
- Five stocks we like better than Aveanna Healthcare
- But this $2 Gold Stock Before May 20, 2026
- The $100 Trillion AI Story No One Is Telling You
- Bombshell Exposé on China Strikes
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
